Journal of the American College of Cardiology

Journal of the American College of Cardiology
source
Title	Journal of the American College of Cardiology
Discipline	Cardiology
Language	English
Abbreviation	JACC
Publisher	Elsevier for the American College of Cardiology
Country	United States
Frequency	Weekly
History	1983–present
Impact	41.165
Impact-year	2022
Issn	0735-1097

Contents

Journal of the American College of Cardiology is a peer-reviewed medical journal focusing on Cardiology and clinical cardiovascular science. Founded in 1983 by the American College of Cardiology and published by Elsevier on behalf of the College, the journal has become a leading outlet for research associated with institutions such as the Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, Brigham and Women's Hospital, and Mount Sinai Health System. Its pages frequently feature work from investigators affiliated with Harvard Medical School, Stanford University School of Medicine, University of California, San Francisco, Columbia University Vagelos College of Physicians and Surgeons, and Yale School of Medicine.

History

The journal was launched amid growth in cardiovascular research led by centers like the National Heart, Lung, and Blood Institute, the American Heart Association, and the European Society of Cardiology. Early editors collaborated with figures associated with New England Journal of Medicine practices, drawing submissions from authors at University of Pennsylvania Perelman School of Medicine, University of Michigan, University of Texas Southwestern Medical Center, and Washington University in St. Louis. Over decades the journal published pivotal randomized trials linked to trials run by groups such as the SYNTAX trial investigators, the STEMI networks architecture, and guideline-setting committees including contributors from the World Health Organization and U.S. Food and Drug Administration. The title evolved alongside advances at research centers like Massachusetts General Hospital and laboratories funded by the National Institutes of Health.

The journal covers clinical trials, translational research, imaging studies, and guideline-focused reviews relevant to practice at centers including Cedars-Sinai Medical Center, Vanderbilt University Medical Center, Duke University School of Medicine, Imperial College London, and Karolinska Institutet. Content types include original articles, editorials involving authors from Oxford University, perspective pieces by contributors from McMaster University, systematic reviews associated with teams at McMaster University and Cochrane, and state-of-the-art reviews reflecting collaborations with American College of Cardiology Foundation committees and specialty societies like the Heart Failure Society of America and the Transcatheter Cardiovascular Therapeutics community. Topics often intersect with device research from Medtronic, pharmacology trials by teams linked to Pfizer and AstraZeneca, and imaging innovations from vendors such as GE Healthcare and Philips.

Editorial leadership has historically included editors-in-chief affiliated with University of Pittsburgh School of Medicine, University of California, Los Angeles School of Medicine, Northwestern University Feinberg School of Medicine, and Indiana University School of Medicine. The journal operates a peer review process drawing reviewers from clinics like St. Thomas' Hospital and research institutes such as Broad Institute and Salk Institute. It follows publishing standards influenced by organizations such as the International Committee of Medical Journal Editors and practices mirrored in titles like The Lancet and BMJ. Production and distribution leverage platforms used by Elsevier and indexing collaborations with entities like Clarivate and Scopus.

The journal is indexed in major services including PubMed, MEDLINE, Science Citation Index Expanded, Scopus, and EMBASE. Citation metrics reported by Clarivate Analytics place it among high-impact cardiovascular journals alongside Circulation, European Heart Journal, JAMA Cardiology, and Heart Rhythm. Abstracting coverage supports discoverability through databases utilized by researchers at Google Scholar, university libraries at University of Cambridge, University of Oxford, and national archives such as the National Library of Medicine.

The journal's impact factor has positioned it among top cardiovascular publications, influencing guideline development by panels with representatives from American Heart Association, European Society of Cardiology, and specialty groups like the Society for Cardiovascular Angiography and Interventions. Landmark papers published in the journal have informed practice at hospitals including Toronto General Hospital and Royal Brompton Hospital, and have been cited by policy documents from agencies such as the Centers for Disease Control and Prevention and regulatory decisions by the European Medicines Agency. Critical reception balances praise for clinical influence with scrutiny typical of high-profile journals observed in commentary from outlets like The New York Times and correspondence within BMJ.

Category:Cardiology journals Category:English-language journals Category:Elsevier academic journals